Cargando…
Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
A new coronavirus respiratory disease (COVID-19) caused by the SARS-CoV-2 virus, surprised the entire world, producing social, economic, and health problems. The COVID-19 triggers a lung infection with a multiple proinflammatory cytokine storm in severe patients. Without effective and safe treatment...
Autores principales: | Riedel, Rodrigo N., Pérez-Pérez, Antonio, Sánchez-Margalet, Víctor, Varone, Cecilia L., Maymó, Julieta L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919997/ https://www.ncbi.nlm.nih.gov/pubmed/33648582 http://dx.doi.org/10.1186/s13287-021-02216-w |
Ejemplares similares
-
Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation
por: Maymó, Julieta L., et al.
Publicado: (2018) -
Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells
por: Riedel, Rodrigo, et al.
Publicado: (2019) -
The Alternative Epac/cAMP Pathway and the MAPK Pathway Mediate hCG Induction of Leptin in Placental Cells
por: Maymó, Julieta Lorena, et al.
Publicado: (2012) -
Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation
por: Toro, Ayelén Rayen, et al.
Publicado: (2014) -
Leptin action in normal and pathological pregnancies
por: Pérez‐Pérez, Antonio, et al.
Publicado: (2017)